Oxygen News and Research

RSS

Enhanced external counterpulsation therapy benefits long COVID-19 patients

In a small study of long COVID-19 patients, those with and without coronary artery disease demonstrated improvement of a variety of symptoms, including fatigue, breathing difficulties and chest discomfort, after undergoing 15-35 hours of enhanced external counterpulsation (EECP) therapy.

14 Feb 2022

Progression of Alzheimer's disease is linked to oxidative brain damage, research confirms

Increased oxidative damage is linked to neurodegenerative disorders such as Alzheimer's disease (AD). Even though the pathophysiology of AD has been widely investigated, the likely relationship between mitochondrial dysfunction and the disease remains largely unknown.

14 Feb 2022

Study identifies a link between mortality of newborns on ECMO and red blood cell transfusion volume

Newborns in respiratory failure who require the life-sustaining support of ECMO also require transfusion of red blood cells. But a new study indicates that the higher volume of these oxygen-carrying blood cells the babies receive, the higher their mortality rate.

14 Feb 2022

Study explores the gut microbiome of COVID-19 patients

Researchers investigated the changes in the gut microbiome and the presence of SARS-CoV-2 in stool samples of COVID-19 patients.

14 Feb 2022

Ketogenic diet could enhance the efficacy of chemotherapy for pancreatic cancer, study shows

A Ludwig Cancer Research preclinical study has demonstrated that a common weight-loss diet could enhance the efficacy of chemotherapy for pancreatic cancer.

12 Feb 2022

Sleep apnea during pregnancy linked to the development of hypertension and metabolic syndrome

In a new study published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine, researchers examined whether sleep disordered breathing (primarily obstructive sleep apnea) during pregnancy and in the years after delivery is associated with an increased risk for hypertension and metabolic syndrome.

12 Feb 2022

Stroke patients have higher chance of better outcomes when treated at Comprehensive Stroke Centers

When comparing outcomes for acute ischemic stroke patients treated at various levels of stroke centers, patients who received care at Comprehensive Stroke Centers (CSC) or Thrombectomy-capable Stroke Centers (TSC) were more likely to receive rapid treatment with clot-busting medication and/or mechanical clot removal and be discharged home or to rehabilitation centers than patients treated at Primary Stroke Centers, according to preliminary research to be presented today at the American Stroke Association's International Stroke Conference 2022.

12 Feb 2022

Mechanical blood clot removal helps nearly half of stroke survivors to achieve good outcomes

Mechanical removal of blood clots reduced post-stroke disability in nearly half of "all-comer" real-world stroke patients in an international study, according to preliminary late-breaking science presented today at the American Stroke Association's International Stroke Conference 2022.

11 Feb 2022

The impact of COVID-19 on people with systemic autoimmune rheumatic diseases

A survey demonstrated that patients with systemic autoimmune rheumatic diseases commonly experience augmented disease severity and disrupted treatment regimens of disease-modifying antirheumatic drugs after acute COVID-19 course.

11 Feb 2022

Newer clot-busting drug may lengthen the window for additional stroke treatment to 24 hours

If patients with clot-caused strokes obtain medical care more than 4½ hours after their symptoms are noticed, it is too late to receive the standard clot-busting medication alteplase.

11 Feb 2022

Being fit can protect older people against mild cognitive impairment

Seventy- to eighty-year-olds who train for better fitness are better at solving cognitive tasks and are less likely to suffer cognitive impairment.

10 Feb 2022

Researchers identify a potent new combination of antiviral drugs to combat SARS-CoV-2

The recent success of Paxlovid has encouraged researchers to develop new anti-covid drugs. With this in mind, scientists from the University of Pennsylvania have been investigating a new synergistic treatment. Their research is released early as an unedited version of the manuscript to be published in the journal Nature.

9 Feb 2022

Addressing sleep-disordered breathing in a hospital can be more effective, WVU program suggests

Sleep-disordered breathing exacerbates obesity, stroke, COPD and heart failure - some of the most prevalent conditions in Appalachia.

9 Feb 2022

Mechanical hearts can generate new muscle tissue in the failing human heart

Mechanical hearts spur some regeneration in dormant parts of failing hearts, according to a UT Southwestern pilot study that shows promise for developing regenerative heart therapies.

8 Feb 2022

The impact of SARS-CoV-2 variants on clinical trajectory and outcome

The current study describes the results of examining a patient database to understand just how Omicron affected the clinical outcome.

8 Feb 2022

SARS-CoV-2 infection can elevate the risk of serious complications during pregnancy

Pregnant individuals infected with SARS-CoV-2, the virus that causes COVID-19, are about 40% more likely to develop serious complications or die during pregnancy than those who aren’t infected with the virus, according to a nationwide study led by a University of Utah Health obstetrician.

7 Feb 2022

Colchicine holds promise to reduce the risk of severe COVID-19

A recent article, published in Rheumatology and Therapy, reviews the potent evidence of colchicine against the SARS-CoV-2 infection.

7 Feb 2022

Cocktail of two chemicals could help slow down age-related muscular decline

Researchers from Tokyo Metropolitan University have shown that a mixture of 5-aminolevulinic acid(5-ALA) hydrochloride and sodium ferrous citrate (SFC) helps slow down aging-related muscular decline in fruit flies, leading to a slower decline in locomotor activity and longer lifespans.

7 Feb 2022

Cerebrovascular impairment persists months after severe acute COVID-19, UK study

Researchers in the United Kingdom have conducted an observational cohort study on hospitalized patients and have found that the degree of severity of acute coronavirus disease 2019 (COVID-19) predicts the occurrence of chronic cerebrovascular impairment. The study further suggests that the levels of cerebrovascular impairment are associated with worse cognitive, mental, and physical well-being.

7 Feb 2022

AI systems may one day assist anesthesiologists in the operating room, study suggests

A new study by researchers at MIT and Massachusetts General Hospital suggests the day may be approaching when advanced artificial intelligence systems could assist anesthesiologists in the operating room.

6 Feb 2022

Oxygen News and Research

Enhanced external counterpulsation therapy benefits long COVID-19 patients

Progression of Alzheimer's disease is linked to oxidative brain damage, research confirms

Study identifies a link between mortality of newborns on ECMO and red blood cell transfusion volume

Study explores the gut microbiome of COVID-19 patients

Ketogenic diet could enhance the efficacy of chemotherapy for pancreatic cancer, study shows

Sleep apnea during pregnancy linked to the development of hypertension and metabolic syndrome

Stroke patients have higher chance of better outcomes when treated at Comprehensive Stroke Centers

Mechanical blood clot removal helps nearly half of stroke survivors to achieve good outcomes

The impact of COVID-19 on people with systemic autoimmune rheumatic diseases

Newer clot-busting drug may lengthen the window for additional stroke treatment to 24 hours

Being fit can protect older people against mild cognitive impairment

Researchers identify a potent new combination of antiviral drugs to combat SARS-CoV-2

Addressing sleep-disordered breathing in a hospital can be more effective, WVU program suggests

Mechanical hearts can generate new muscle tissue in the failing human heart

The impact of SARS-CoV-2 variants on clinical trajectory and outcome

SARS-CoV-2 infection can elevate the risk of serious complications during pregnancy

Colchicine holds promise to reduce the risk of severe COVID-19

Cocktail of two chemicals could help slow down age-related muscular decline

Cerebrovascular impairment persists months after severe acute COVID-19, UK study

AI systems may one day assist anesthesiologists in the operating room, study suggests

Oxygen Measurement eBook - Easily Understand Dissolved Oxygen Measurement eBook

Latest eBooks

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Driving innovation in Korean drug development

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC